Molecular Pharmacology to Acquire Topical Cox-2 Inhibitor Candidate as Part of Australian Transaction LOS ANGELES, May 3, 2006 (PRIMEZONE) -- Molecular Pharmacology (USA) Limited (OTCBB:MLPH) announced today the discovery of a new topically applied COX-2 inhibitor drug candidate MPL-356, following...

Molecular Pharmacology Announces Shareholder Approval to Acquire Drug Development Company Following Special Meeting of Shareholders LOS ANGELES, April 25, 2006 (PRIMEZONE) -- Molecular Pharmacology (USA) Limited (OTCBB:MLPH) is pleased to announce that at the special meeting of shareholders of the Corporation held on April 21,...